Tue, September 11, 2012
Mon, September 10, 2012
Sun, September 9, 2012
Fri, September 7, 2012
Thu, September 6, 2012
Wed, September 5, 2012
Tue, September 4, 2012
Mon, September 3, 2012
Sun, September 2, 2012
Sat, September 1, 2012
Fri, August 31, 2012
Thu, August 30, 2012
Wed, August 29, 2012
Tue, August 28, 2012

ARIAD to Present at Upcoming Investor Conferences


//health-fitness.news-articles.net/content/2012/ .. to-present-at-upcoming-investor-conferences.html
Published in Health and Fitness on Tuesday, September 4th 2012 at 4:48 GMT by Market Wire   Print publication without navigation


CAMBRIDGE, Mass.--([ ])--[ ARIAD Pharmaceuticals, Inc. ] (NASDAQ: ARIA) today announced that Harvey J. Berger, M.D., chairman and chief executive officer, will provide an overview of the Companyas business at two upcoming investor conferences being held next week:

  • The Rodman & Renshaw 14th Annual Healthcare Conference in New York City. Dr. Bergeras presentation is on Monday, September 10 at 12:05 p.m. (ET)
  • The Morgan Stanley Global Healthcare Conference in New York City. Dr. Bergeras presentation is on Tuesday, September 11 at 3:00 p.m. (ET)

Both presentations will be webcast live and can be accessed by visiting the investor relations section of the Company's website at [ http://www.ariad.com/investor ]. A replay of the presentation will also be available and archived on the site for three weeks.

About ARIAD

ARIAD Pharmaceuticals, Inc. is an emerging global oncology company focused on the discovery, development and commercialization of medicines to transform the lives of cancer patients. ARIADas approach to structure-based drug design has led to several internally discovered, molecularly targeted product candidates for drug-resistant or difficult-to-treat cancers, including certain forms of chronic myeloid leukemia and non-small cell lung cancer. For additional information, visit [ http://www.ariad.com ] or follow ARIAD on [ Twitter ] (@ARIADPharm).


Publication Contributing Sources